Nanoparticle delivery for metastatic breast cancer
Related Experiment Video
Updated: May 24, 2026
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Stephen R Grobmyer1, Guangyin Zhou, Luke G Gutwein
1Division of Surgical Oncology, Department of Surgery, University of Florida, Gainesville, FL 32610, USA. Stephen.Grobmyer@surgery.ufl.edu
Abstract:
Breast cancer represents a major ongoing public health problem as the most common non-cutaneous malignancy among U.S. women. While significant progress has been made in improving loco-regional treatments for breast cancer, relatively little progress has been made in diagnosing and treating patients with metastatic breast cancer. At present there are limited curative options for patients with breast cancer metastatic beyond regional nodes. Emerging nanotechnologies promise new approaches to early detection and treatment of metastatic breast cancer. Fulfilling the promise of nanotechnologies for patients with metastatic breast cancer will require delivery of nanomaterials to sites of metastatic disease. Future translational approaches will rely on an ever increasing understanding of the biology of breast cancer subtypes and their metastases. These important concepts will be highlighted and elucidated in this manuscript.
Insights
Nanotechnology offers new hope for diagnosing and treating metastatic breast cancer, which currently has limited curative options. Further research into nanomaterial delivery and cancer biology is crucial for clinical success.
Area of Science:
- Oncology
- Nanotechnology
- Biomedical Engineering
Background:
- Breast cancer is a leading cause of cancer death in U.S. women.
- Loco-regional treatments have advanced, but metastatic breast cancer diagnosis and treatment remain challenging.
- Limited curative options exist for patients with metastatic breast cancer beyond regional lymph nodes.
Purpose of the Study:
- To highlight the potential of nanotechnology in early detection and treatment of metastatic breast cancer.
- To emphasize the need for effective nanomaterial delivery to metastatic sites.
- To underscore the importance of understanding breast cancer biology for future translational approaches.
Main Methods:
- Review of current literature on breast cancer metastasis and nanotechnology applications.
- Discussion of challenges and opportunities in nanomaterial delivery for metastatic disease.
- Exploration of the role of cancer subtype biology in treatment strategies.
Main Results:
- Nanotechnologies present promising avenues for improving metastatic breast cancer outcomes.
- Successful application of nanomedicine requires targeted delivery of nanomaterials to metastatic lesions.
- Advancements in understanding breast cancer subtypes and metastasis are essential for progress.
Conclusions:
- Nanotechnology holds significant promise for advancing metastatic breast cancer care.
- Targeted delivery and a deeper understanding of cancer biology are key to realizing this promise.
- This work emphasizes the critical need for continued research and development in nanomedicine for breast cancer.
